Day 1 › Friday, 19th September

Poster Session 1

Chairs: F. Albrecht – S. Cattaneo – P. Esposito – M. Marengo – P. Raimondo – I. Riva- M. Thielmann – M. A. Valsecchi

Cardio

P78

A light in the dark: Pancreatic Stone Protein doesn’t seem to be affected by immunosuppressive induction therapy in cardio-surgery patientsTamburri G, Raimondo P, Rubino G, Lenoci S, Armenise A, Pica F, Villani M.A, Fiore G, Grasso S
Bari (Italy)

P79

Successful employment of VA ECMO and blood purification in cardiogenic/septic shock: a 2 cases seriesRaimondo P, Favale A, Squiccimarro E, Verde G, Nompleggio A, Labriola C
Bari (Italy), Mercogliano (Italy), Maastricht ( The Netherlands)

P80

Pancreatic Stone Protein (PSP) correlates with the clinical severity of patients underwent heart transplantation and cardiac surgeryRaimondo P, Tamburri G, Rubino G, Lenoci S, Armenise A, Pica F, Villani M.A, Fiore G, Grasso S
Bari (Italy)

P82

Cytosorb Hemoadsorption for Dabigatran Removal in Emergency Mitral Valve Surgery: A Case ReportQuerio S, Contri R, Ottria C, Contino A, Serra M, Audo A, Maj G
Alessandria (Italy)

P83

Emergency Cardiac Operations in Patients at High Risk of Bleeding – a single centre experienceD’Apollo N, Spezie C, Brandi M, Braccini M.S, Fontanesi L, Mascheroni G, Tolio V, Sita M, Meli M
Modena (Italy)

P84

Clinical use of CytoSorb® as adjuvant therapy during CPB in patients with sepsis for bacterial endocarditis and hypothermic cardiac arrestDelgado D.F, D’Apollo N, Spezie C, Brandi M, Braccini M.S, Mascheroni G, Tolio V, Fontanesi L, Meli M
Havana (Cuba), Modena (Italy)

P85

P87

Use of cytosorb during cardiopulmonary bypass and circulatory arrest in acute aortic dissection surgeryGigliotti G, Franzese I, Fierro N, Gripshi F, Tassone M.R, Sasso F, Grassi P, Mazzaro E
Trieste (Italy)

P88

Use of CytoSorb in patient with refractory vasoplegic shockPadovano F.P, Della Malva E, Damato I, Caso A, Distaso F, Nardi M, Greco F
San Giovanni Rotondo (Italy)

P89

Extracorporeal Blood Purification with CytoSorb® in Patients with Shock: Standalone Circuit Configuration Versus Integrated Use Within Extracorporeal Membrane OxygenationD’Andria Ursoleo j, Pieri M, Bonizzoni M, Pontillo D, Francescon C, Scaglia T, Gambirasio A, Nardelli P, Ortalda A, Turla G, Zangrillo A, Ajello S, Scandroglio A.M
Milano (Italy)

P90

Efficacy of Hemoadsorption Therapy in the Dabigatran Removal: a case reportGerini U, Ianche F, Giannattasio F, Giacomini A, Guidone B, Pecorari M, Russo S, Tosto M
Latisana (Italy), Palmanova (Italy)

P91

Hemoperfusion with CytoSorb in pediatric age: a valid therapeutic option in the treatment of refractory cardiogenic shock in septic patientsSpasiano A, Caporossi E, De Vigili A, Gottin L, Pertica N, Gambaro G, Ferraro P.M
Verona (Italy)

P92

Hemadsorption in Cardiogenic Shock: a case reportRago A, Andrao L, Celiz Becerra L.R, Albertini A, Panzera G, Diano A, Bertolani G, Barbieri A, Leal Camacho J.E
Reggio Emilia (Italy), Modena (Italy)

P93

Hemodynamic and Metabolic Impact of CytoSorb in ECMO-Supported PatientsRibera C, Bozzini S, Pellegrini C, Mimmi M.C, Rampino T, Belliato M
Pavia (Italy)

P95

Use of hemoadsoprtion after Frozen Elephant Trunk for an ascending aortic aneurysmVitale A, Ascione L, Cerullo G, Oliviero A, Catapano D, Cangiano G, Allocca S, Di Maio S, Fulco E, Ferrone O, Rondinella R, Moscariello C, De Crescenzo U
Castel Volturno (Italy), Napoli (Italy)

P96

Ultrafiltration nefrocardiocare, our experienceStaffieri V, Porcelluzzi A, Strangio C, Vaccariello R, Zona A, Piccolo T
Barletta (Italy)